<!DOCTYPE html >
<html lang="en">
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p182" style="overflow: hidden; position: relative; background-color: white; width: 433px; height: 649px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	-webkit-transform-origin: top left;
	-moz-transform-origin: top left;
	-o-transform-origin: top left;
	-ms-transform-origin: top left;
	-webkit-transform: scale(0.25);
	-moz-transform: scale(0.25);
	-o-transform: scale(0.25);
	-ms-transform: scale(0.25);
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_182{left:4px;top:233px;letter-spacing:-0.1px;}
#t2_182{left:4px;top:78px;letter-spacing:-0.3px;}
#t3_182{left:4px;top:629px;}
#t4_182{left:43px;top:40px;letter-spacing:-0.9px;word-spacing:-0.3px;}
#t5_182{left:113px;top:69px;}
#t6_182{left:50px;top:157px;}
#t7_182{left:49px;top:348px;}
#t8_182{left:49px;top:360px;}
#t9_182{left:84px;top:372px;}
#ta_182{left:57px;top:405px;}
#tb_182{left:48px;top:417px;word-spacing:-0.1px;}
#tc_182{left:176px;top:157px;}
#td_182{left:181px;top:287px;}
#te_182{left:185px;top:299px;}
#tf_182{left:180px;top:331px;}
#tg_182{left:193px;top:343px;}
#th_182{left:179px;top:375px;}
#ti_182{left:185px;top:387px;}
#tj_182{left:185px;top:400px;}
#tk_182{left:305px;top:376px;}
#tl_182{left:310px;top:389px;}
#tm_182{left:304px;top:401px;}
#tn_182{left:310px;top:413px;}
#to_182{left:319px;top:425px;}
#tp_182{left:307px;top:437px;}
#tq_182{left:309px;top:450px;}
#tr_182{left:300px;top:462px;}
#ts_182{left:294px;top:474px;}
#tt_182{left:314px;top:486px;}
#tu_182{left:48px;top:178px;}
#tv_182{left:54px;top:178px;}
#tw_182{left:55px;top:190px;}
#tx_182{left:71px;top:202px;}
#ty_182{left:97px;top:214px;}
#tz_182{left:58px;top:227px;}
#t10_182{left:82px;top:239px;}
#t11_182{left:53px;top:251px;}
#t12_182{left:78px;top:263px;}
#t13_182{left:78px;top:275px;}
#t14_182{left:54px;top:288px;}
#t15_182{left:83px;top:300px;}
#t16_182{left:56px;top:312px;}
#t17_182{left:89px;top:324px;}
#t18_182{left:202px;top:178px;}
#t19_182{left:192px;top:190px;}
#t1a_182{left:214px;top:202px;}
#t1b_182{left:185px;top:214px;}
#t1c_182{left:191px;top:227px;}
#t1d_182{left:223px;top:239px;}
#t1e_182{left:187px;top:251px;}
#t1f_182{left:190px;top:263px;}
#t1g_182{left:288px;top:178px;}
#t1h_182{left:294px;top:178px;}
#t1i_182{left:294px;top:190px;}
#t1j_182{left:294px;top:202px;}
#t1k_182{left:294px;top:214px;}
#t1l_182{left:288px;top:227px;}
#t1m_182{left:294px;top:227px;}
#t1n_182{left:294px;top:239px;}
#t1o_182{left:288px;top:251px;}
#t1p_182{left:288px;top:263px;}
#t1q_182{left:288px;top:275px;}
#t1r_182{left:294px;top:275px;}
#t1s_182{left:294px;top:288px;}
#t1t_182{left:294px;top:300px;}
#t1u_182{left:288px;top:312px;}
#t1v_182{left:288px;top:324px;}
#t1w_182{left:146px;top:95px;}
#t1x_182{left:121px;top:107px;}
#t1y_182{left:150px;top:119px;}
#t1z_182{left:153px;top:131px;}
#t20_182{left:284px;top:168px;}
#t21_182{left:43px;top:518px;letter-spacing:-0.9px;word-spacing:-0.2px;}
#t22_182{left:52px;top:536px;letter-spacing:-1px;}
#t23_182{left:59px;top:536px;letter-spacing:-1px;}
#t24_182{left:105px;top:536px;letter-spacing:-1px;word-spacing:1.8px;}
#t25_182{left:59px;top:551px;letter-spacing:-1px;}
#t26_182{left:52px;top:568px;letter-spacing:-1px;word-spacing:-0.2px;}
#t27_182{left:203px;top:568px;letter-spacing:-0.9px;word-spacing:-0.2px;}
#t28_182{left:61px;top:586px;letter-spacing:-1px;word-spacing:-0.1px;}

.s1_182{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: AllerDisplay_lq;
	color: rgb(156,100,158);
}

.s2_182{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: AllerDisplay_lq;
	color: rgb(35,31,32);
}

.s3_182{
	FONT-SIZE: 39.7px;
	FONT-FAMILY: AllerDisplay_lq;
	color: rgb(255,255,255);
}

.s4_182{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: Helvetica-Condensed-Bold_j0;
	color: rgb(35,31,32);
}

.s5_182{
	FONT-SIZE: 36.7px;
	FONT-FAMILY: Helvetica-Condensed-Bold_j0;
	color: rgb(35,31,32);
}

.s6_182{
	FONT-SIZE: 36.7px;
	FONT-FAMILY: Helvetica-Condensed_ix;
	color: rgb(35,31,32);
}

.s7_182{
	FONT-SIZE: 195.6px;
	FONT-FAMILY: Helvetica-Condensed_ix;
	color: rgb(35,31,32);
}

.s8_182{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: Helvetica-Condensed_ix;
	color: rgb(35,31,32);
}

.t.m0_182{
	-webkit-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
	-ms-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
	-moz-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
	-o-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
}

.t.m1_182{
	-webkit-transform: matrix(-1,0,0,1,0, 0) scale(0.25);
	-ms-transform: matrix(-1,0,0,1,0, 0) scale(0.25);
	-moz-transform: matrix(-1,0,0,1,0, 0) scale(0.25);
	-o-transform: matrix(-1,0,0,1,0, 0) scale(0.25);
}

</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts182" type="text/css" >

@font-face {
	font-family: Helvetica-Condensed-Bold_j0;
	src: url("fonts/Helvetica-Condensed-Bold_j0.woff") format("woff");
}

@font-face {
	font-family: AllerDisplay_lq;
	src: url("fonts/AllerDisplay_lq.woff") format("woff");
}

@font-face {
	font-family: Helvetica-Condensed_ix;
	src: url("fonts/Helvetica-Condensed_ix.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg182Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg182" style="-webkit-user-select: none;"><object width="433" height="649" data="182/182.svg" type="image/svg+xml" id="pdf182" style="width:433px; height:649px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div id="t1_182" class="t m0_182 s1_182">O Guia do Jovem Internista </div>
<div id="t2_182" class="t m0_182 s2_182">2016</div>
<div id="t3_182" class="t s3_182">180</div>
<div id="t4_182" class="t s4_182">• Esquemas terapêuticos</div>
<div id="t5_182" class="t s5_182">Tromboembolismo Venoso</div>
<div id="t6_182" class="t s6_182">Anticoagulantes Orais Diretos</div>
<div id="t7_182" class="t s6_182">Monitorização de hemograma </div>
<div id="t8_182" class="t s6_182">e função renal cerca de 1 mês </div>
<div id="t9_182" class="t s6_182">após início</div>
<div id="ta_182" class="t s6_182">Seguimento regular, com </div>
<div id="tb_182" class="t s6_182">controlo de função renal anual</div>
<div id="tc_182" class="t s6_182">Antagonistas da Vitamina K</div>
<div id="td_182" class="t s6_182">Avaliação de lN R às 48h </div>
<div id="te_182" class="t s6_182">a 72h após a 1 a toma</div>
<div id="tf_182" class="t s6_182">Ajuste de acordo com I N </div>
<div id="tg_182" class="t s6_182">R alvo pretendido</div>
<div id="th_182" class="t s6_182">Após INR estável monito-</div>
<div id="ti_182" class="t s6_182">rização periódica (não</div>
<div id="tj_182" class="t s6_182">superior a 4 semanas)</div>
<div id="tk_182" class="t s5_182">Classe mais </div>
<div id="tl_182" class="t s5_182">eficaz em</div>
<div id="tm_182" class="t s5_182">doentes com </div>
<div id="tn_182" class="t s5_182">neoplasia</div>
<div id="to_182" class="t s5_182">ativa</div>
<div id="tp_182" class="t s5_182">Se possível </div>
<div id="tq_182" class="t s5_182">completar</div>
<div id="tr_182" class="t s5_182">anticoagulação</div>
<div id="ts_182" class="t s5_182">com HBPM nestes </div>
<div id="tt_182" class="t s5_182">doentes</div>
<div id="tu_182" class="t s6_182">- </div>
<div id="tv_182" class="t s6_182">Rivaroxabano 15mg 2xd de </div>
<div id="tw_182" class="t s6_182">12/12h durante 3 semanas, </div>
<div id="tx_182" class="t s6_182">depois 20mg 1 xd</div>
<div id="ty_182" class="t s6_182">ou</div>
<div id="tz_182" class="t s6_182">Necessária a terapêutica </div>
<div id="t10_182" class="t s6_182">inicial com</div>
<div id="t11_182" class="t s6_182">HBPM durante pelo menos </div>
<div id="t12_182" class="t s6_182">7 a 10 dias e</div>
<div id="t13_182" class="t s6_182">depois inicia:</div>
<div id="t14_182" class="t s6_182">- Dabigatrano 150mg 2xd, </div>
<div id="t15_182" class="t s6_182">de 12/12h</div>
<div id="t16_182" class="t s6_182">- Apixabano 5mg 2xd, de </div>
<div id="t17_182" class="t s6_182">12/12h</div>
<div id="t18_182" class="t s6_182">Necessária a </div>
<div id="t19_182" class="t s6_182">sobreposição com </div>
<div id="t1a_182" class="t s6_182">HBPM</div>
<div id="t1b_182" class="t s6_182">(pelo menos 3-5 dias) </div>
<div id="t1c_182" class="t s6_182">até INR terapêutico</div>
<div id="t1d_182" class="t s6_182">+</div>
<div id="t1e_182" class="t s6_182">Varfarina 2.5 a 10mg </div>
<div id="t1f_182" class="t s6_182">(ou Acenocumarol)</div>
<div id="t1g_182" class="t s6_182">- </div>
<div id="t1h_182" class="t s6_182">Enoxaparina lmg/</div>
<div id="t1i_182" class="t s6_182">Kg 2xd, de 12/12h, </div>
<div id="t1j_182" class="t s6_182">se (ou lxd se TFG &lt; </div>
<div id="t1k_182" class="t s6_182">30ml/min/1.73)</div>
<div id="t1l_182" class="t s6_182">- </div>
<div id="t1m_182" class="t s6_182">Dalteparina 200UI/</div>
<div id="t1n_182" class="t s6_182">kg/d ou lOOUI/Kg</div>
<div id="t1o_182" class="t s6_182">12/12h (até 18.000/d) </div>
<div id="t1p_182" class="t s6_182">se</div>
<div id="t1q_182" class="t s6_182">- </div>
<div id="t1r_182" class="t s6_182">Nadroparina </div>
<div id="t1s_182" class="t s6_182">0,1ml/10kgs </div>
<div id="t1t_182" class="t s6_182">12/12h se</div>
<div id="t1u_182" class="t s6_182">- Tinzaparina 175U/</div>
<div id="t1v_182" class="t s6_182">Kg lxd, se</div>
<div id="t1w_182" class="t s6_182">2 Opções</div>
<div id="t1x_182" class="t s6_182">- Preferência do doente</div>
<div id="t1y_182" class="t s6_182">- Custo</div>
<div id="t1z_182" class="t s6_182">- TFG</div>
<div id="t20_182" class="t m1_182 s7_182">}</div>
<div id="t21_182" class="t s4_182">• Reversão de acção</div>
<div id="t22_182" class="t s4_182">- </div>
<div id="t23_182" class="t s4_182">Heparina </div>
<div id="t24_182" class="t s8_182">- sulfato de protamina - 1mg por cada 100U ev adminis-</div>
<div id="t25_182" class="t s8_182">tradas</div>
<div id="t26_182" class="t s4_182">- Anticoagulantes Orais Diretos</div>
<div id="t27_182" class="t s8_182">- nem todos têm antídoto específico</div>
<div id="t28_182" class="t s8_182">- Medidas de hemostase gerais + reforço de diurese</div>

<!-- End text definitions -->


</div>
</body>
</html>
